Scholars Central

Research articlePublished 30 Dec 2013

Antibiotic Prophylaxis in Colorectal Surgery: Evolving Trends

Authors: Peter A Ongom, Stephen C Kijjambu

1Colorectal Unit, Department of Surgery, School of Medicine, Makerere University College of Health Sciences, Makerere University, Kampala, Uganda; 2Department of Surgery, School of Medicine, Makerere University College of Health Sciences, Makerere University, Kampala, Uganda

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Surgical antibiotic prophylaxis has become standard practice for patients undergoing colorectal surgery. This clinical practice has changed greatly over the last three decades, and it is currently accepted worldwide. It is phenomenal in minimizing postoperative wound infection in elective surgery. Clinical practice guidelines have been developed to herald this. However, the practice is yet to be established in some regions, particularly lowincome countries. A review of the evolution of the practice is necessary. Clinical Overview: Being a clean-contaminated procedure, colorectal surgery is a typical indication for antibiotic prophylaxis. The antibiotic for use is chosen on the basis of – its activity against endogenous flora likely to be encountered, its toxicity, and its cost, in that order. Controversy persists concerning the route of administration (oral, intravenous, or both), the number of administrations, and the duration of prophylaxis. Potent antibiotics used for serious infections are essentially not used for this purpose. A maximum dose is given preoperatively so that effective tissue concentration is present at and after the time of incision. In the absence of infection, the antibiotic is discontinued after the operative day. Systematic improvements in the timing of initial administration, the appropriate choice of antibiotic agents, and shorter durations of administration have added value to the practice, with reductions in postoperative surgical infections, especially surgical site infections, for colorectal (clean-contaminated) procedures. The prevention of surgical site infections is an objective contained in the WHO Guidelines for Safe Surgery. They are a potentially morbid and costly complication following major colorectal surgery. Conclusions: The practice of prophylaxis in surgery continues to improve. In recent years, growing attention is being placed on the accurate identification and monitoring of surgical complications and their costs. Advancements in antibiotic development and usage will translate into better prophylactic measures, which alongside other measures for control of surgical infections will give a better outcome for colorectal surgery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Pharmaceutics & Organic Process Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Pharmaceutics & Organic Process Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Peter A Ongom”
  • BylineArticles whose byline prints “Stephen C Kijjambu”